Department of Dermatology, University of Cincinnati College of Medicine Cincinnati, OH, USA.
Ther Clin Risk Manag. 2007 Mar;3(1):29-40. doi: 10.2147/tcrm.2007.3.1.29.
Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used.
自身免疫性大疱性疾病是由针对桥粒或基底膜分子成分的免疫反应引起的。大疱性疾病与高度发病率和偶发性死亡率相关。大疱性疾病的治疗包括抑制免疫系统、控制炎症和改善侵蚀的愈合。用于治疗大疱性疾病的治疗剂可能与高发病率和偶发性死亡率相关。成功的治疗需要了解疾病过程的病理生理学和所用药物的药理学。